Ignite Creation Date:
2025-12-24 @ 3:44 PM
Ignite Modification Date:
2026-02-03 @ 8:47 PM
Study NCT ID:
NCT06902792
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2025-03-30
First Post:
2025-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adebrelimab Combined With Trametinib in the Treatment of Refractory Recurrent Langerhans Cell Histiocytosis in Children and Adolescents
Sponsor:
Second Affiliated Hospital of Wenzhou Medical University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Histiocytosis, Langerhans-Cell | View |
Keywords: